druckenSitemap

Aktuelle Publikationen aus 2015 - 2017

Hier sind die nationalen und internationalen Fachpublikationen der Mitglieder des Kompetenznetzes Demenzen e.V. in Form einer bibliografischen Liste aufgeführt. Die Sortierung erfolgt alphabetisch.

 

A

 

Agís-Balboa RC, Pinheiro PS, Rebola N, Kerimoglu C, Benito E, Gertig M, u. a. Formin 2 links neuropsychiatric phenotypes at young age to an increased risk for dementia. EMBO J. 2. Oktober 2017;36(19):2815–28.

Aisen PS, Cummings J, Jack CR, Morris JC, Sperling R, Frölich L, u. a. On the path to 2025: understanding the Alzheimer’s disease continuum. Alzheimers Res Ther. 9. August 2017;9(1):60.

Albi A, Pasternak O, Minati L, Marizzoni M, Bartrés-Faz D, Bargalló N, u. a. Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects. Hum Brain Mapp. Januar 2017;38(1):12–26.

Alexopoulos P, Gleixner L-S, Werle L, Buhl F, Thierjung N, Giourou E, u. a. Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer’s disease. Eur Arch Psychiatry Clin Neurosci. 10. Juni 2017;

Alexopoulos P, Kurz A. The New Conceptualization of Alzheimer’s Disease under the Microscope of Influential Definitions of Disease. Psychopathology. 2015;48(6):359–67.

Alexopoulos P, Roesler J, Thierjung N, Werle L, Buck D, Yakushev I, u. a. Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer’s disease. Eur Arch Psychiatry Clin Neurosci. Oktober 2016;266(7):587–97.

Alexopoulos P, Roesler J, Werle L, Thierjung N, Lentzari I, Ortner M, u. a. Fluid biomarker agreement and interrelation in dementia due to Alzheimer’s disease. J Neural Transm (Vienna). 15. November 2017;

Alves GS, Oertel Knöchel V, Knöchel C, Carvalho AF, Pantel J, Engelhardt E, u. a. Integrating retrogenesis theory to Alzheimer’s disease pathology: insight from DTI-TBSS investigation of the white matter microstructural integrity. Biomed Res Int. 2015;2015:291658.

Andrejeva N, Knebel M, Dos Santos V, Schmidt J, Herold CJ, Tudoran R, u. a. Neurocognitive Deficits and Effects of Cognitive Reserve in Mild Cognitive Impairment. Dement Geriatr Cogn Disord. 2016;41(3–4):199–209.

Arendt T, Morawski M, Gärtner U, Fröhlich N, Schulze F, Wohmann N, u. a. Inhomogeneous distribution of Alzheimer pathology along the isocortical relief. Are cortical convolutions an Achilles heel of evolution? Brain Pathol. September 2017;27(5):603–11.



B

 

Baldacci F, Toschi N, Lista S, Zetterberg H, Blennow K, Kilimann I, u. a. Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer’s disease. Alzheimers Dement. September 2017;13(9):993–1003.

Barrera-Ocampo A, Arlt S, Matschke J, Hartmann U, Puig B, Ferrer I, u. a. Amyloid-β Precursor Protein Modulates the Sorting of Testican-1 and Contributes to Its Accumulation in Brain Tissue and Cerebrospinal Fluid from Patients with Alzheimer Disease. J Neuropathol Exp Neurol. September 2016;75(9):903–16.

Barucker C, Sommer A, Beckmann G, Eravci M, Harmeier A, Schipke CG, u. a. Alzheimer amyloid peptide aβ42 regulates gene expression of transcription and growth factors. J Alzheimers Dis. 2015;44(2):613–24.

Berger C, Erbe A-K, Ehlers I, Marx I, Hauenstein K, Teipel S. Effects of task-irrelevant emotional stimuli on working memory processes in mild cognitive impairment. J Alzheimers Dis. 2015;44(2):439–53.

Bey K, Wolfsgruber S, Karaca I, Wagner H, Lardenoije R, Becker J, u. a. No association of the variant rs11887120 in DNMT3A with cognitive decline in individuals with mild cognitive impairment. Epigenomics. Mai 2016;8(5):593–8.

Bisenius S, Mueller K, Diehl-Schmid J, Fassbender K, Grimmer T, Jessen F, u. a. Predicting primary progressive aphasias with support vector machine approaches in structural MRI data. Neuroimage Clin. 2017;14:334–43.

Blautzik J, Keeser D, Paolini M, Kirsch V, Berman A, Coates U, u. a. Functional connectivity increase in the default-mode network of patients with Alzheimer’s disease after long-term treatment with Galantamine. Eur Neuropsychopharmacol. März 2016;26(3):602–13.

Bleckwenn M, Kleineidam L, Wagner M, Jessen F, Weyerer S, Werle J, u. a. Impact of coronary heart disease on cognitive decline in Alzheimer’s disease: a prospective longitudinal cohort study in primary care. Br J Gen Pract. Februar 2017;67(655):e111–7.

Boccardi M, Bocchetta M, Morency FC, Collins DL, Nishikawa M, Ganzola R, u. a. Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol. Alzheimers Dement. Februar 2015;11(2):175–83.

Bocchetta M, Galluzzi S, Kehoe PG, Aguera E, Bernabei R, Bullock R, u. a. The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey. Alzheimers Dement. Februar 2015;11(2):195–206.e1.

Bokde ALW, Cavedo E, Lopez-Bayo P, Lista S, Meindl T, Born C, u. a. Effects of rivastigmine on visual attention in subjects with amnestic mild cognitive impairment: A serial functional MRI activation pilot-study. Psychiatry Res. 30. März 2016;249:84–90.

Bos I, Vos SJ, Frölich L, Kornhuber J, Wiltfang J, Maier W, u. a. The frequency and influence of dementia risk factors in prodromal Alzheimer’s disease. Neurobiol Aging. August 2017;56:33–40.

Bronner K, Perneczky R, McCabe R, Kurz A, Hamann J. Which medical and social decision topics are important after early diagnosis of Alzheimer’s Disease from the perspectives of people with Alzheimer’s Disease, spouses and professionals? BMC Res Notes. 8. März 2016;9:149.

Brueggen K, Dyrba M, Barkhof F, Hausner L, Filippi M, Nestor PJ, u. a. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer’s Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study. J Alzheimers Dis. 2015;48(1):197–204.

Brueggen K, Fiala C, Berger C, Ochmann S, Babiloni C, Teipel SJ. Early Changes in Alpha Band Power and DMN BOLD Activity in Alzheimer’s Disease: A Simultaneous Resting State EEG-fMRI Study. Front Aging Neurosci. 2017;9:319.

Brueggen K, Grothe MJ, Dyrba M, Fellgiebel A, Fischer F, Filippi M, u. a. The European DTI Study on Dementia - A multicenter DTI and MRI study on Alzheimer’s disease and Mild Cognitive Impairment. Neuroimage. Januar 2017;144(Pt B):305–8.

Brueggen K, Kasper E, Dyrba M, Bruno D, Pomara N, Ewers M, u. a. The Primacy Effect in Amnestic Mild Cognitive Impairment: Associations with Hippocampal Functional Connectivity. Front Aging Neurosci. 2016;8:244.

Brueggen K, Kasper E, Ochmann S, Pfaff H, Webel S, Schneider W, u. a. Cognitive Rehabilitation in Alzheimer’s Disease: A Controlled Intervention Trial. J Alzheimers Dis. 2017;57(4):1315–24.

Bruno D, Ciarleglio A, Grothe MJ, Nierenberg J, Bachman AH, Teipel SJ, u. a. Hippocampal volume and integrity as predictors of cognitive decline in intact elderly. Neuroreport. 3. August 2016;27(11):869–73.

Bruno D, Grothe MJ, Nierenberg J, Zetterberg H, Blennow K, Teipel SJ, u. a. A study on the specificity of the association between hippocampal volume and delayed primacy performance in cognitively intact elderly individuals. Neuropsychologia. März 2015;69:1–8.

Bruno D, Grothe MJ, Nierenberg J, Teipel SJ, Zetterberg H, Blennow K, u. a. The relationship between CSF tau markers, hippocampal volume and delayed primacy performance in cognitively intact elderly individuals. Alzheimers Dement (Amst). 1. März 2015;1(1):81–6.

Bruno D, Grothe MJ, Nierenberg J, Sidtis JJ, Teipel SJ, Pomara N. Output order and variability in free recall are linked to cognitive ability and hippocampal volume in elderly individuals. Neuropsychologia. 8. Januar 2016;80:126–32.

Bucerius J, Barthel H, Tiepolt S, Werner P, Sluimer JC, Wildberger JE, u. a. Feasibility of in vivo 18F-florbetaben PET/MR imaging of human carotid amyloid-β. Eur J Nucl Med Mol Imaging. Juli 2017;44(7):1119–28.


C

 

Cavedo E, Grothe MJ, Colliot O, Lista S, Chupin M, Dormont D, u. a. Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer’s disease. Sci Rep. 15. September 2017;7(1):11706.

Cavedo E, Lista S, Rojkova K, Chiesa PA, Houot M, Brueggen K, u. a. Disrupted white matter structural networks in healthy older adult APOE ε4 carriers - An international multicenter DTI study. Neuroscience. 15. August 2017;357:119–33.

Cummings J, Aisen PS, DuBois B, Frölich L, Jack CR, Jones RW, u. a. Drug development in Alzheimer’s disease: the path to 2025. Alzheimers Res Ther. 20. September 2016;8:39.


D

Daria A, Colombo A, Llovera G, Hampel H, Willem M, Liesz A, u. a. Young microglia restore amyloid plaque clearance of aged microglia. EMBO J. 1. März 2017;36(5):583–603.

Degen C, Toro P, Schönknecht P, Sattler C, Schröder J. Diabetes mellitus Type II and cognitive capacity in healthy aging, mild cognitive impairment and Alzheimer’s disease. Psychiatry Res. 30 2016;240:42–6.

Degen C, Zschocke J, Toro P, Sattler C, Wahl H-W, Schönknecht P, u. a. The COMTp.Val158Met Polymorphism and Cognitive Performance in Adult Development, Healthy Aging and Mild Cognitive Impairment. Dement Geriatr Cogn Disord. 2016;41(1–2):27–34.

Denk J, Boelmans K, Siegismund C, Lassner D, Arlt S, Jahn H. MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease. PLoS ONE. 2015;10(5):e0126423.

Duits FH, Martinez-Lage P, Paquet C, Engelborghs S, Lleó A, Hausner L, u. a. Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study. Alzheimers Dement. Februar 2016;12(2):154–63.

Dyrba M, Barkhof F, Fellgiebel A, Filippi M, Hausner L, Hauenstein K, u. a. Predicting Prodromal Alzheimer’s Disease in Subjects with Mild Cognitive Impairment Using Machine Learning Classification of Multimodal Multicenter Diffusion-Tensor and Magnetic Resonance Imaging Data. J Neuroimaging. Oktober 2015;25(5):738–47.

Dyrba M, Grothe MJ, Mohammadi A, Binder H, Kirste T, Teipel SJ, u. a. Comparison of Different Hypotheses Regarding the Spread of Alzheimer’s Disease Using Markov Random Fields and Multimodal Imaging. J Alzheimers Dis. 1. Juli 2017;

Dyrba M, Grothe M, Kirste T, Teipel SJ. Multimodal analysis of functional and structural disconnection in Alzheimer’s disease using multiple kernel SVM. Hum Brain Mapp. Juni 2015;36(6):2118–31.


E

Eichler T, Thyrian JR, Hertel J, Michalowsky B, Wucherer D, Dreier A, u. a. Rates of formal diagnosis of dementia in primary care: The effect of screening. Alzheimers Dement (Amst). März 2015;1(1):87–93.

Eichler T, Thyrian JR, Hertel J, Wucherer D, Michalowsky B, Reiner K, u. a. Subjective memory impairment: No suitable criteria for case-finding of dementia in primary care. Alzheimers Dement (Amst). Juni 2015;1(2):179–86.

Eichler T, Thyrian JR, Hertel J, Richter S, Wucherer D, Michalowsky B, u. a. Unmet Needs of Community-Dwelling Primary Care Patients with Dementia in Germany: Prevalence and Correlates. J Alzheimers Dis. 2016;51(3):847–55.

Eichler T, Thyrian JR, Hertel J, Richter S, Michalowsky B, Wucherer D, u. a. Patient Variables Associated with the Assignment of a Formal Dementia Diagnosis to Positively Screened Primary Care Patients. Curr Alzheimer Res. 7. September 2017;

Eichler T, Wucherer D, Thyrian JR, Kilimann I, Hertel J, Michalowsky B, u. a. Antipsychotic drug treatment in ambulatory dementia care: prevalence and correlates. J Alzheimers Dis. 2015;43(4):1303–11.

Engelborghs S, Niemantsverdriet E, Struyfs H, Blennow K, Brouns R, Comabella M, u. a. Consensus guidelines for lumbar puncture in patients with neurological diseases. Alzheimers Dement (Amst). 2017;8:111–26.

Escott-Price V, Sims R, Bannister C, Harold D, Vronskaya M, Majounie E, u. a. Common polygenic variation enhances risk prediction for Alzheimer’s disease. Brain. Dezember 2015;138(Pt 12):3673–84.

Estrella M, Roberts A, Mäurer A, Fiebach J, Buchert R, Steinhagen-Thiessen E, u. a. [Acceptance of dementia diagnostics by getriatric hospital patients : Comparison of various investigation methods with emphasis on FDG-PET imaging]. Z Gerontol Geriatr. Januar 2017;50(1):52–8.

Ewers M, Mattsson N, Minthon L, Molinuevo JL, Antonell A, Popp J, u. a. CSF biomarkers for the differential diagnosis of Alzheimer’s disease: A large-scale international multicenter study. Alzheimers Dement. November 2015;11(11):1306–15.


 

F

Falkai P, Malchow B, Wetzestein K, Nowastowski V, Bernstein H-G, Steiner J, u. a. Decreased Oligodendrocyte and Neuron Number in Anterior Hippocampal Areas and the Entire Hippocampus in Schizophrenia: A Stereological Postmortem Study. Schizophr Bull. Juli 2016;42 Suppl 1:S4–12.

Fellhauer I, Zöllner FG, Schröder J, Degen C, Kong L, Essig M, u. a. Comparison of automated brain segmentation using a brain phantom and patients with early Alzheimer’s dementia or mild cognitive impairment. Psychiatry Res. 30. September 2015;233(3):299–305.

Fleck D, Voss M, Brankatschk B, Giudici C, Hampel H, Schwenk B, u. a. Proteolytic Processing of Neuregulin 1 Type III by Three Intramembrane-cleaving Proteases. J Biol Chem. 1. Januar 2016;291(1):318–33.

Fleckenstein J, Matura S, Engeroff T, Füzéki E, Tesky VA, Pilatus U, u. a. SMART: physical activity and cerebral metabolism in older people: study protocol for a randomised controlled trial. Trials. 11. April 2015;16:155.

Franzmann J, Haberstroh J, Pantel J. Train the trainer in dementia care. A program to foster communication skills in nursing home staff caring for dementia patients. Z Gerontol Geriatr. April 2016;49(3):209–15.

Franzmeier N, Buerger K, Teipel S, Stern Y, Dichgans M, Ewers M, u. a. Cognitive reserve moderates the association between functional network anti-correlations and memory in MCI. Neurobiol Aging. Februar 2017;50:152–62.

Freytag V, Carrillo-Roa T, Milnik A, Sämann PG, Vukojevic V, Coynel D, u. a. A peripheral epigenetic signature of immune system genes is linked to neocortical thickness and memory. Nat Commun. 26. April 2017;8:15193.

Frings L, Spehl TS, Hüll M, Meyer PT. Left Anterior Temporal Glucose Metabolism and not Amyloid-beta Load Predicts Naming Impairment in Alzheimer’s Disease. Curr Alzheimer Res. 2016;13(6):678–81.

Frisoni GB, Boccardi M, Barkhof F, Blennow K, Cappa S, Chiotis K, u. a. Strategic roadmap for an early diagnosis of Alzheimer’s disease based on biomarkers. Lancet Neurol. August 2017;16(8):661–76.

Frisoni GB, Jack CR, Bocchetta M, Bauer C, Frederiksen KS, Liu Y, u. a. The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: evidence of validity. Alzheimers Dement. Februar 2015;11(2):111–25.

Fritze T, Teipel S, Óvári A, Kilimann I, Witt G, Doblhammer G. Hearing Impairment Affects Dementia Incidence. An Analysis Based on Longitudinal Health Claims Data in Germany. PLoS ONE. 2016;11(7):e0156876.

Frölich L, Müller WE, Riederer P. Editorial: Siegfried Hoyer’s concept of Alzheimer pathophysiology. J Neural Transm (Vienna). April 2015;122(4):495–7.

Frölich L, Peters O, Lewczuk P, Gruber O, Teipel SJ, Gertz HJ, u. a. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia. Alzheimers Res Ther. 10. Oktober 2017;9(1):84.


 

 

G

 

Galluzzi S, Marizzoni M, Babiloni C, Albani D, Antelmi L, Bagnoli C, u. a. Clinical and biomarker profiling of prodromal Alzheimer’s disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a „European ADNI study“. J Intern Med. Juni 2016;279(6):576–91.

Gomm W, von Holt K, Thomé F, Broich K, Maier W, Fink A, u. a. Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis. JAMA Neurol. April 2016;73(4):410–6.

Gonzalez-Escamilla G, Lange C, Teipel S, Buchert R, Grothe MJ, Alzheimer’s Disease Neuroimaging Initiative. PETPVE12: an SPM toolbox for Partial Volume Effects correction in brain PET - Application to amyloid imaging with AV45-PET. Neuroimage. 15. Februar 2017;147:669–77.

Gorenc-Mahmutaj L, Degen C, Wetzel P, Urbanowitsch N, Funke J, Schröder J. The Positivity Effect on the Intensity of Experienced Emotion and Memory Performance in Mild Cognitive Impairment and Dementia. Dement Geriatr Cogn Dis Extra. August 2015;5(2):233–43.

Görtz P, Siebler M, Ihl R, Henning U, Luckhaus C, Supprian T, u. a. Multielectrode array analysis of cerebrospinal fluid in Alzheimer’s disease versus mild cognitive impairment: a potential diagnostic and treatment biomarker. Biochem Biophys Res Commun. 3. Mai 2013;434(2):293–7.

Granert O, Drzezga AE, Boecker H, Perneczky R, Kurz A, Götz J, u. a. Metabolic Topology of Neurodegenerative Disorders: Influence of Cognitive and Motor Deficits. J Nucl Med. Dezember 2015;56(12):1916–21.

Grimmer T, Beringer S, Kehl V, Alexopoulos P, Busche A, Förstl H, u. a. Trends of patient referral to a memory clinic and towards earlier diagnosis from 1985-2009. Int Psychogeriatr. Dezember 2015;27(12):1939–44.

Grimmer T, Wutz C, Alexopoulos P, Drzezga A, Förster S, Förstl H, u. a. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment. J Nucl Med. Februar 2016;57(2):204–7.

Gronewold J, Klafki H-W, Baldelli E, Kaltwasser B, Seidel UK, Todica O, u. a. Factors Responsible for Plasma β-Amyloid Accumulation in Chronic Kidney Disease. Mol Neurobiol. Juli 2016;53(5):3136–45.

Gronewold J, Todica O, Klafki H-W, Seidel UK, Kaltwasser B, Wiltfang J, u. a. Association of Plasma β-Amyloid with Cognitive Performance and Decline in Chronic Kidney Disease. Mol Neurobiol. 29. Oktober 2016;

Grothe MJ, Heinsen H, Amaro E, Grinberg LT, Teipel SJ. Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment. Cereb Cortex. 2016;26(6):2411–26.

Grothe MJ, Teipel SJ, Alzheimer’s Disease Neuroimaging Initiative. Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer’s disease correspond to dissociable functional brain networks. Hum Brain Mapp. Januar 2016;37(1):35–53.


H

 

Hajek A, Brettschneider C, Eisele M, Lühmann D, Mamone S, Wiese B, u. a. Disentangling the complex relation of disability and depressive symptoms in old age - findings of a multicenter prospective cohort study in Germany. Int Psychogeriatr. Juni 2017;29(6):885–95.

Hajek A, Brettschneider C, Ernst A, Posselt T, Wiese B, Prokein J, u. a. Longitudinal predictors of informal and formal caregiving time in community-dwelling dementia patients. Soc Psychiatry Psychiatr Epidemiol. April 2016;51(4):607–16.

Hajek A, Brettschneider C, Lange C, Posselt T, Wiese B, Steinmann S, u. a. Longitudinal Predictors of Institutionalization in Old Age. PLoS ONE. 2015;10(12):e0144203.

Hajek A, Brettschneider C, Lühmann D, Eisele M, Mamone S, Wiese B, u. a. Effect of Visual Impairment on Physical and Cognitive Function in Old Age: Findings of a Population-Based Prospective Cohort Study in Germany. J Am Geriatr Soc. November 2016;64(11):2311–6.

Halbgebauer S, Nagl M, Klafki H, Haußmann U, Steinacker P, Oeckl P, u. a. Modified serpinA1 as risk marker for Parkinson’s disease dementia: Analysis of baseline data. Sci Rep. 17. Mai 2016;6:26145.

Heck A, Fastenrath M, Coynel D, Auschra B, Bickel H, Freytag V, u. a. Genetic Analysis of Association Between Calcium Signaling and Hippocampal Activation, Memory Performance in the Young and Old, and Risk for Sporadic Alzheimer Disease. JAMA Psychiatry. Oktober 2015;72(10):1029–36.

Heilmann S, Drichel D, Clarimon J, Fernández V, Lacour A, Wagner H, u. a. PLD3 in non-familial Alzheimer’s disease. Nature. 2. April 2015;520(7545):E3-5.

Hellwig K, Kvartsberg H, Portelius E, Andreasson U, Oberstein TJ, Lewczuk P, u. a. Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease. Alzheimers Res Ther. 24. Dezember 2015;7:74.

Henz S, Ackl N, Knels C, Rominger A, Flatz W, Teipel S, u. a. [A Pair of Siblings with a rare R5H-Mutation in Exon 1 of the MAPT-Gene]. Fortschr Neurol Psychiatr. Juli 2015;83(7):397–401.

Herold CJ, Lässer MM, Schmid LA, Seidl U, Kong L, Fellhauer I, u. a. Neuropsychology, autobiographical memory, and hippocampal volume in „younger“ and „older“ patients with chronic schizophrenia. Front Psychiatry. 2015;6:53.

Heser K, Bleckwenn M, Wiese B, Mamone S, Riedel-Heller SG, Stein J, u. a. Late-Life Depressive Symptoms and Lifetime History of Major Depression: Cognitive Deficits are Largely Due to Incipient Dementia rather than Depression. J Alzheimers Dis. 1. August 2016;54(1):185–99.

Heser K, Luck T, Röhr S, Wiese B, Kaduszkiewicz H, Oey A, u. a. Potentially inappropriate medication: Association between the use of antidepressant drugs and the subsequent risk for dementia. J Affect Disord. 15. Januar 2018;226:28–35.

Hessler JB, Schäufele M, Hendlmeier I, Nora Junge M, Leonhardt S, Weber J, u. a. The 6-Item Cognitive Impairment Test as a bedside screening for dementia in general hospital patients: results of the General Hospital Study (GHoSt). Int J Geriatr Psychiatry. Juli 2017;32(7):726–33.

Hirjak D, Sambataro F, Remmele B, Kubera KM, Schröder J, Seidl U, u. a. The relevance of hippocampal subfield integrity and clock drawing test performance for the diagnosis of Alzheimer’s disease and mild cognitive impairment. World J Biol Psychiatry. 31. August 2017;1–12.

Hirjak D, Wolf RC, Pfeifer B, Kubera KM, Thomann AK, Seidl U, u. a. Cortical signature of clock drawing performance in Alzheimer’s disease and mild cognitive impairment. J Psychiatr Res. Juli 2017;90:133–42.

Hirjak D, Wolf RC, Remmele B, Seidl U, Thomann AK, Kubera KM, u. a. Hippocampal formation alterations differently contribute to autobiographic memory deficits in mild cognitive impairment and Alzheimer’s disease. Hippocampus. Juni 2017;27(6):702–15.

Hurlemann R, Maier W, Scheele D. Interactions of noradrenaline and cortisol and the induction of indelible memories. Behav Brain Sci. Januar 2016;39:e213.


 

J

 

Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FRJ, u. a. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA. 19. Mai 2015;313(19):1924–38.

Jekel K, Damian M, Storf H, Hausner L, Frölich L. Development of a Proxy-Free Objective Assessment Tool of Instrumental Activities of Daily Living in Mild Cognitive Impairment Using Smart Home Technologies. J Alzheimers Dis. 2016;52(2):509–17.

Jekel K, Damian M, Wattmo C, Hausner L, Bullock R, Connelly PJ, u. a. Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review. Alzheimers Res Ther. 2015;7(1):17.

Jun G, Ibrahim-Verbaas CA, Vronskaya M, Lambert J-C, Chung J, Naj AC, u. a. A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry. Januar 2016;21(1):108–17.


K

 

Kasper E, Thöne-Otto A, Bürger K, Schröder SG, Hoffmann W, Schneider W, u. a. [Cognitive rehabilitation in early stage Alzheimer’s disease]. Nervenarzt. Juli 2016;87(7):708–18.

Kasper E, Brueggen K, Grothe MJ, Bruno D, Pomara N, Unterauer E, u. a. Neuronal correlates of serial position performance in amnestic mild cognitive impairment. Neuropsychology. November 2016;30(8):906–14.

Kilimann I, Hausner L, Fellgiebel A, Filippi M, Würdemann TJ, Heinsen H, u. a. Parallel Atrophy of Cortex and Basal Forebrain Cholinergic System in Mild Cognitive Impairment. Cereb Cortex. 1. März 2017;27(3):1841–8.

Kilimann I, Thyrian JR, Hoffmann W, Teipel SJ. Translation of imaging biomarkers from clinical research to healthcare. Z Gerontol Geriatr. Mai 2017;50(Suppl 2):84–8.

Klafki H-W, Hafermann H, Bauer C, Haussmann U, Kraus I, Schuchhardt J, u. a. Validation of a Commercial Chemiluminescence Immunoassay for the Simultaneous Measurement of Three Different Amyloid-β Peptides in Human Cerebrospinal Fluid and Application to a Clinical Cohort. J Alzheimers Dis. 6. September 2016;54(2):691–705.

Kljajevic V, Dyrba M, Kasper E, Teipel S. Is the left uncinate fasciculus associated with verbal fluency decline in mild Alzheimer’s disease? Transl Neurosci. 2016;7(1):89–91.

Klöppel S, Peter J, Ludl A, Pilatus A, Maier S, Mader I, u. a. Applying Automated MR-Based Diagnostic Methods to the Memory Clinic: A Prospective Study. J Alzheimers Dis. 2015;47(4):939–54.

Klotz A-L, Hassel AJ, Schröder J, Rammelsberg P, Zenthöfer A. Oral health-related quality of life and prosthetic status of nursing home residents with or without dementia. Clin Interv Aging. 2017;12:659–65.

Knebel M, Haberstroh J, Kümmel A, Pantel J, Schröder J. CODEMamb - an observational communication behavior assessment tool for use in ambulatory dementia care. Aging Ment Health. Dezember 2016;20(12):1286–96.

Köbe T, Witte AV, Schnelle A, Grittner U, Tesky VA, Pantel J, u. a. Vitamin B-12 concentration, memory performance, and hippocampal structure in patients with mild cognitive impairment. Am J Clin Nutr. April 2016;103(4):1045–54.

Köbe T, Witte AV, Schnelle A, Lesemann A, Fabian S, Tesky VA, u. a. Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment. Neuroimage. 1. Mai 2016;131:226–38.

Köbe T, Witte AV, Schnelle A, Tesky VA, Pantel J, Schuchardt J-P, u. a. Impact of Resveratrol on Glucose Control, Hippocampal Structure and Connectivity, and Memory Performance in Patients with Mild Cognitive Impairment. Front Neurosci. 2017;11:105.

Koppara A, Frommann I, Polcher A, Parra MA, Maier W, Jessen F, u. a. Feature Binding Deficits in Subjective Cognitive Decline and in Mild Cognitive Impairment. J Alzheimers Dis. 24. September 2015;48 Suppl 1:S161-170.

Koppara A, Wagner M, Lange C, Ernst A, Wiese B, König H-H, u. a. Cognitive performance before and after the onset of subjective cognitive decline in old age. Alzheimers Dement (Amst). Juni 2015;1(2):194–205.

Koppara A, Wolfsgruber S, Kleineidam L, Schmidtke K, Frölich L, Kurz A, u. a. The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment. J Alzheimers Dis. 2016;49(2):547–60.

Kowoll ME, Degen C, Gladis S, Schröder J. Neuropsychological profiles and verbal abilities in lifelong bilinguals with mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis. 2015;45(4):1257–68.

Kowoll ME, Degen C, Gorenc L, Küntzelmann A, Fellhauer I, Giesel F, u. a. Bilingualism as a Contributor to Cognitive Reserve? Evidence from Cerebral Glucose Metabolism in Mild Cognitive Impairment and Alzheimer’s Disease. Front Psychiatry. 2016;7:62.

Kranaster L, Aksay SS, Bumb JM, Janke C, Alonso A, Hoyer C, u. a. Electroconvulsive therapy selectively enhances amyloid β 1-42 in the cerebrospinal fluid of patients with major depression: A prospective pilot study. Eur Neuropsychopharmacol. Dezember 2016;26(12):1877–84.

Kuhla A, Rühlmann C, Lindner T, Polei S, Hadlich S, Krause BJ, u. a. APPswe/PS1dE9 mice with cortical amyloid pathology show a reduced NAA/Cr ratio without apparent brain atrophy: A MRS and MRI study. Neuroimage Clin. 2017;15:581–6.

Kurz A, Bakker C, Böhm M, Diehl-Schmid J, Dubois B, Ferreira C, u. a. RHAPSODY - Internet-based support for caregivers of people with young onset dementia: program design and methods of a pilot study. Int Psychogeriatr. Dezember 2016;28(12):2091–9.

Kvartsberg H, Portelius E, Andreasson U, Brinkmalm G, Hellwig K, Lelental N, u. a. Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls. Alzheimers Res Ther. 2015;7(1):40.


L

 

Lacour A, Espinosa A, Louwersheimer E, Heilmann S, Hernández I, Wolfsgruber S, u. a. Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer’s disease among subjects with mild cognitive impairment. Mol Psychiatry. Januar 2017;22(1):153–60.

Lahr J, Peter J, Minkova L, Lauer E, Reis J, Heimbach B, u. a. Reply to „Motor cortex plasticity in subjects with mild cognitive impairment“. Clin Neurophysiol. 2016;127(6):2337–8.

Lahr J, Peter J, Minkova L, Lauer E, Reis J, Heimbach B, u. a. No difference in paired associative stimulation induced cortical neuroplasticity between patients with mild cognitive impairment and elderly controls. Clin Neurophysiol. Februar 2016;127(2):1254–60.

Lang V, Zille M, Infante-Duarte C, Jarius S, Jahn H, Paul F, u. a. Alzheimer’s disease: Elevated pigment epithelium-derived factor in the cerebrospinal fluid is mostly of systemic origin. J Neurol Sci. 15. April 2017;375:123–8.

Lange C, Suppa P, Pietrzyk U, Makowski MR, Spies L, Peters O, u. a. Prediction of Alzheimer’s Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status. J Alzheimers Dis. 14. November 2017;

Lelental N, Brandner S, Kofanova O, Blennow K, Zetterberg H, Andreasson U, u. a. Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics. J Alzheimers Dis. 01 2016;52(1):51–64.

Levin J, Kurz A, Arzberger T, Giese A, Höglinger GU. The Differential Diagnosis and Treatment of Atypical Parkinsonism. Dtsch Arztebl Int. 5. Februar 2016;113(5):61–9.

Lewczuk P, Kornhuber J. Do we still need positron emission tomography for early Alzheimer’s disease diagnosis? Brain. 1. November 2016;139(11):e60.

Lewczuk P, Kornhuber J, German Dementia Competence Network, Toledo JB, Trojanowski JQ, Knapik-Czajka M, u. a. Validation of the Erlangen Score Algorithm for the Prediction of the Development of Dementia due to Alzheimer’s Disease in Pre-Dementia Subjects. J Alzheimers Dis. 2015;48(2):433–41.

Lewczuk P, Kornhuber J, Toledo JB, Trojanowski JQ, Knapik-Czajka M, Peters O, u. a. Validation of the Erlangen Score Algorithm for the Prediction of the Development of Dementia due to Alzheimer’s Disease in Pre-Dementia Subjects. J Alzheimers Dis. 2016;49(3):887.

Lewczuk P, Lelental N, Spitzer P, Maler JM, Kornhuber J. Amyloid-β 42/40 cerebrospinal fluid concentration ratio in the diagnostics of Alzheimer’s disease: validation of two novel assays. J Alzheimers Dis. 2015;43(1):183–91.

Lewczuk P, Matzen A, Blennow K, Parnetti L, Molinuevo JL, Eusebi P, u. a. Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease. J Alzheimers Dis. 2017;55(2):813–22.

Lewczuk P, Mroczko B, Fagan A, Kornhuber J. Biomarkers of Alzheimer’s disease and mild cognitive impairment: a current perspective. Adv Med Sci. März 2015;60(1):76–82.

Lewczuk P, Riederer P, O’Bryant SE, Verbeek MM, Dubois B, Visser PJ, u. a. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. World J Biol Psychiatry. 27. Oktober 2017;1–85.

Lill CM, Rengmark A, Pihlstrøm L, Fogh I, Shatunov A, Sleiman PM, u. a. The role of TREM2 R47H as a risk factor for Alzheimer’s disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson’s disease. Alzheimers Dement. Dezember 2015;11(12):1407–16.

Lista S, Molinuevo JL, Cavedo E, Rami L, Amouyel P, Teipel SJ, u. a. Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline. J Alzheimers Dis. 24. September 2015;48 Suppl 1:S171-191.

Lista S, Toschi N, Baldacci F, Zetterberg H, Blennow K, Kilimann I, u. a. Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study. J Alzheimers Dis. 2017;59(4):1327–34.

Lista S, Toschi N, Baldacci F, Zetterberg H, Blennow K, Kilimann I, u. a. Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer’s disease. Neurochem Int. September 2017;108:355–60.

Louwersheimer E, Wolfsgruber S, Espinosa A, Lacour A, Heilmann-Heimbach S, Alegret M, u. a. Alzheimer’s disease risk variants modulate endophenotypes in mild cognitive impairment. Alzheimers Dement. August 2016;12(8):872–81.

Lovestone S, Boada M, Dubois B, Hüll M, Rinne JO, Huppertz H-J, u. a. A phase II trial of tideglusib in Alzheimer’s disease. J Alzheimers Dis. 2015;45(1):75–88.

Luck T, Luppa M, Matschinger H, Jessen F, Angermeyer MC, Riedel-Heller SG. Incident subjective memory complaints and the risk of subsequent dementia. Acta Psychiatr Scand. April 2015;131(4):290–6.

Luck T, Riedel-Heller SG, Roehr S, Wiese B, van der Leeden C, Heser K, u. a. Mortality in Incident Cognitive Impairment: Results of the Prospective AgeCoDe Study. J Am Geriatr Soc. April 2017;65(4):738–46.

Luck T, Rodriguez FS, Wiese B, van der Leeden C, Heser K, Bickel H, u. a. Advance directives and power of attorney for health care in the oldest-old - results of the AgeQualiDe study. BMC Geriatr. 13. April 2017;17(1):85.

Luck T, Roehr S, Jessen F, Villringer A, Angermeyer MC, Riedel-Heller SG. Mortality in Individuals with Subjective Cognitive Decline: Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). J Alzheimers Dis. 24. September 2015;48 Suppl 1:S33-42.


M

 

Maier W. Searching biomarkers for mental disorders-lessons from Alzheimer’s disease. Eur Arch Psychiatry Clin Neurosci. Oktober 2016;266(7):583–5.

Marizzoni M, Antelmi L, Bosch B, Bartrés-Faz D, Müller BW, Wiltfang J, u. a. Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly. Hum Brain Mapp. September 2015;36(9):3516–27.

Matura S, Fleckenstein J, Deichmann R, Engeroff T, Füzéki E, Hattingen E, u. a. Effects of aerobic exercise on brain metabolism and grey matter volume in older adults: results of the randomised controlled SMART trial. Transl Psychiatry. 18. Juli 2017;7(7):e1172.

Matura S, Carvalho AF, Alves GS, Pantel J. Physical Exercise for the Treatment of Neuropsychiatric Disturbances in Alzheimer’s Dementia: Possible Mechanisms, Current Evidence and Future Directions. Curr Alzheimer Res. 2016;13(10):1112–23.

Megges H, Freiesleben SD, Jankowski N, Haas B, Peters O. Technology for home dementia care: A prototype locating system put to the test. Alzheimers Dement (N Y). September 2017;3(3):332–8.

Mehrabian S, Alexopoulos P, Ortner M, Traykov L, Grimmer T, Kurz A, u. a. Cerebrospinal fluid biomarkers for Alzheimer’s disease: the role of apolipoprotein E genotype, age, and sex. Neuropsychiatr Dis Treat. 2015;11:3105–10.

Mengel D, Thelen M, Balzer-Geldsetzer M, Söling C, Bach J-P, Schaeffer E, u. a. TREM2 rare variant p.R47H is not associated with Parkinson’s disease. Parkinsonism Relat Disord. Februar 2016;23:109–11.

Michalowsky B, Flessa S, Hertel J, Goetz O, Hoffmann W, Teipel S, u. a. Cost of diagnosing dementia in a German memory clinic. Alzheimers Res Ther. 22. August 2017;9(1):65.

Millenaar JK, Bakker C, Koopmans RTCM, Verhey FRJ, Kurz A, de Vugt ME. The care needs and experiences with the use of services of people with young-onset dementia and their caregivers: a systematic review. Int J Geriatr Psychiatry. Dezember 2016;31(12):1261–76.

Millenaar JK, Bakker C, van Vliet D, Koopmans RTCM, Kurz A, Verhey FRJ, u. a. Exploring perspectives of young onset dementia caregivers with high versus low unmet needs. Int J Geriatr Psychiatry. 23. Juni 2017;

Molinuevo JL, Frölich L, Grossberg GT, Galvin JE, Cummings JL, Krahnke T, u. a. Responder analysis of a randomized comparison of the 13.3 mg/24 h and 9.5 mg/24 h rivastigmine patch. Alzheimers Res Ther. 2015;7(1):9.

Molinuevo JL, Rabin LA, Amariglio R, Buckley R, Dubois B, Ellis KA, u. a. Implementation of subjective cognitive decline criteria in research studies. Alzheimers Dement. März 2017;13(3):296–311.

Morgen K, Frölich L. The metabolism hypothesis of Alzheimer’s disease: from the concept of central insulin resistance and associated consequences to insulin therapy. J Neural Transm (Vienna). April 2015;122(4):499–504.

Morgen K, Schneider M, Frölich L, Tost H, Plichta MM, Kölsch H, u. a. Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer’s disease: a voxel-based lesion mapping study. Alzheimers Res Ther. 2015;7(1):27.

Mroczko B, Groblewska M, Zboch M, Muszyński P, Zajkowska A, Borawska R, u. a. Evaluation of visinin-like protein 1 concentrations in the cerebrospinal fluid of patients with mild cognitive impairment as a dynamic biomarker of Alzheimer’s disease. J Alzheimers Dis. 2015;43(3):1031–7.

Mueller T, Haberstroh J, Knebel M, Oswald F, Kaspar R, Kemper CJ, u. a. Assessing capacity to consent to treatment with cholinesterase inhibitors in dementia using a specific and standardized version of the MacArthur Competence Assessment Tool (MacCAT-T). Int Psychogeriatr. Februar 2017;29(2):333–43.

Müller S, Preische O, Göpfert JC, Yañez VAC, Joos TO, Boecker H, u. a. Tau plasma levels in subjective cognitive decline: Results from the DELCODE study. Sci Rep. 25. August 2017;7(1):9529.


N

 

Nabers A, Ollesch J, Schartner J, Kötting C, Genius J, Hafermann H, u. a. Amyloid-β-Secondary Structure Distribution in Cerebrospinal Fluid and Blood Measured by an Immuno-Infrared-Sensor: A Biomarker Candidate for Alzheimer’s Disease. Anal Chem. 1. März 2016;88(5):2755–62.

Nathan PJ, Lim YY, Abbott R, Galluzzi S, Marizzoni M, Babiloni C, u. a. Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI). Neurobiol Aging. 2017;53:1–10.


 

O

 

Oberstein TJ, Spitzer P, Klafki H-W, Linning P, Neff F, Knölker H-J, u. a. Astrocytes and microglia but not neurons preferentially generate N-terminally truncated Aβ peptides. Neurobiol Dis. Januar 2015;73:24–35.

Ochmann S, Dyrba M, Grothe MJ, Kasper E, Webel S, Hauenstein K, u. a. Does Functional Connectivity Provide a Marker for Cognitive Rehabilitation Effects in Alzheimer’s Disease? An Interventional Study. J Alzheimers Dis. 2017;57(4):1303–13.

Oikonomidi A, Lewczuk P, Kornhuber J, Smulders Y, Linnebank M, Semmler A, u. a. Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta. J Neurochem. Oktober 2016;139(2):324–32.

Ortner M, Pasquini L, Barat M, Alexopoulos P, Grimmer T, Förster S, u. a. Progressively Disrupted Intrinsic Functional Connectivity of Basolateral Amygdala in Very Early Alzheimer’s Disease. Front Neurol. 2016;7:132.


 

P

 

Pajonk F-G, Kessler H, Supprian T, Hamzei P, Bach D, Schweickhardt J, u. a. Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer’s disease. J Alzheimers Dis. September 2005;8(1):23–7.

Pantel J. [Neurocognitive disorders in old age : Role of pharmacotherapy in prevention and treatment]. Internist (Berl). Oktober 2016;57(10):1029–36.

Pantel J. [Alzheimer’s disease from Auguste Deter to the present : Progress, disappointments and open questions]. Z Gerontol Geriatr. Oktober 2017;50(7):576–87.

Pasquini L, Scherr M, Tahmasian M, Myers NE, Ortner M, Kurz A, u. a. Increased Intrinsic Activity of Medial-Temporal Lobe Subregions is Associated with Decreased Cortical Thickness of Medial-Parietal Areas in Patients with Alzheimer’s Disease Dementia. J Alzheimers Dis. 2016;51(1):313–26.

Peter J, Kaiser J, Landerer V, Köstering L, Kaller CP, Heimbach B, u. a. Category and design fluency in mild cognitive impairment: Performance, strategy use, and neural correlates. Neuropsychologia. Dezember 2016;93(Pt A):21–9.

Peter J, Lahr J, Minkova L, Lauer E, Grothe MJ, Teipel S, u. a. Contribution of the Cholinergic System to Verbal Memory Performance in Mild Cognitive Impairment. J Alzheimers Dis. 18. Juni 2016;53(3):991–1001.

Peters O, Heuser I, Frölich L, Rüther E, Rienhoff O, Kornhuber J, u. a. [Dementia Competence Network. Results and outlook]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. April 2016;59(4):438–43.

Peters O, Fuentes M, Joachima LK, Jessen F, Luckhaus C, Kornhuber J, Pantel J, Hüll M, Schmidtke K, Rüther E, Möllerh HJ, Kurz A, Wiltfang J, Maier W, Wiese B, Frölich L, Heuser I. Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug naïve patients with mild to moderate Alzheimer's disease. Alzheimer’s & Dementia: Translational Research & Clinical Interventions. 2015; 1 (3): 198-204.

Popp J, Wolfsgruber S, Heuser I, Peters O, Hüll M, Schröder J, u. a. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer’s type. Neurobiol Aging. Februar 2015;36(2):601–7.


 

R

 

Ramirez A, Wolfsgruber S, Lange C, Kaduszkiewicz H, Weyerer S, Werle J, u. a. Elevated HbA1c is associated with increased risk of incident dementia in primary care patients. J Alzheimers Dis. 2015;44(4):1203–12.

Ray NJ, Metzler-Baddeley C, Khondoker MR, Grothe MJ, Teipel S, Wright P, u. a. Cholinergic basal forebrain structure influences the reconfiguration of white matter connections to support residual memory in mild cognitive impairment. J Neurosci. 14. Januar 2015;35(2):739–47.

Reijs BLR, Vos SJB, Soininen H, Lötjonen J, Koikkalainen J, Pikkarainen M, u. a. Association Between Later Life Lifestyle Factors and Alzheimer’s Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study. J Alzheimers Dis. 2017;60(4):1387–95.

Ritter K, Lange C, Weygandt M, Mäurer A, Roberts A, Estrella M, u. a. Combination of Structural MRI and FDG-PET of the Brain Improves Diagnostic Accuracy in Newly Manifested Cognitive Impairment in Geriatric Inpatients. J Alzheimers Dis. 18. Oktober 2016;54(4):1319–31.

Roehr S, Luck T, Heser K, Fuchs A, Ernst A, Wiese B, u. a. Incident Subjective Cognitive Decline Does Not Predict Mortality in the Elderly--Results from the Longitudinal German Study on Ageing, Cognition, and Dementia (AgeCoDe). PLoS ONE. 2016;11(1):e0147050.

Roehr S, Luck T, Pabst A, Bickel H, König H-H, Lühmann D, u. a. Subjective cognitive decline is longitudinally associated with lower health-related quality of life. Int Psychogeriatr. Dezember 2017;29(12):1939–50.

Roehr S, Villringer A, Angermeyer MC, Luck T, Riedel-Heller SG. Outcomes of stable and unstable patterns of subjective cognitive decline - results from the Leipzig Longitudinal Study of the Aged (LEILA75+). BMC Geriatr. 4. November 2016;16(1):180.

Rullmann M, Dukart J, Hoffmann K-T, Luthardt J, Tiepolt S, Patt M, u. a. Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans. J Nucl Med. Februar 2016;57(2):198–203.


S

 

Sabbagh MN, Schäuble B, Anand K, Richards D, Murayama S, Akatsu H, u. a. Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer’s Disease. J Alzheimers Dis. 2017;56(2):441–6.

Savastano A, Klafki H, Haußmann U, Oberstein TJ, Muller P, Wirths O, u. a. N-Truncated Aβ 2-X Starting with Position Two in Sporadic Alzheimer’s Disease Cases and Two Alzheimer Mouse Models. J Alzheimers Dis. 24. September 2015;

Savastano A, Klafki H, Haußmann U, Oberstein TJ, Muller P, Wirths O, u. a. N-truncated Aβ2-X starting with position two in sporadic Alzheimer’s disease cases and two Alzheimer mouse models. J Alzheimers Dis. 2016;49(1):101–10.

Scheltens NME, Tijms BM, Koene T, Barkhof F, Teunissen CE, Wolfsgruber S, u. a. Cognitive subtypes of probable Alzheimer’s disease robustly identified in four cohorts. Alzheimers Dement. November 2017;13(11):1226–36.

Schikowski T, Vossoughi M, Vierkötter A, Schulte T, Teichert T, Sugiri D, u. a. Association of air pollution with cognitive functions and its modification by APOE gene variants in elderly women. Environ Res. Oktober 2015;142:10–6.

Schipke CG, Koglin N, Bullich S, Joachim LK, Haas B, Seibyl J, u. a. Correlation of florbetaben PET imaging and the amyloid peptide Aß42 in cerebrospinal fluid. Psychiatry Res. 30. Juli 2017;265:98–101.

Schönecker S, Brendel M, Huber M, Vollmar C, Huppertz H-J, Teipel S, u. a. Applied multimodal diagnostics in a case of presenile dementia. BMC Neurol. 9. August 2016;16:131.

Schröder J, Pantel J. Neuroimaging of hippocampal atrophy in early recognition of Alzheimer’s disease--a critical appraisal after two decades of research. Psychiatry Res. 30. Januar 2016;247:71–8.

Schulte EC, Fukumori A, Mollenhauer B, Hor H, Arzberger T, Perneczky R, u. a. Rare variants in β-Amyloid precursor protein (APP) and Parkinson’s disease. Eur J Hum Genet. Oktober 2015;23(10):1328–33.

Schulte EC, Kurz A, Alexopoulos P, Hampel H, Peters A, Gieger C, u. a. Excess of rare coding variants in PLD3 in late- but not early-onset Alzheimer’s disease. Hum Genome Var. 2015;2:14028.

Schütz L, Lobsien D, Fritzsch D, Tiepolt S, Werner P, Schroeter ML, u. a. Feasibility and acceptance of simultaneous amyloid PET/MRI. Eur J Nucl Med Mol Imaging. November 2016;43(12):2236–43.

Schwichtenberg J, Al-Zghloul M, Kerl HU, Wenz H, Hausner L, Frölich L, u. a. Late-onset major depression is associated with age-related white matter lesions in the brainstem. Int J Geriatr Psychiatry. April 2017;32(4):446–54.

Shen Y, Wang H, Sun Q, Yao H, Keegan AP, Mullan M, u. a. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer’s Disease Dementia in Individuals With Mild Cognitive Impairment. Biol Psychiatry. 27. März 2017;

Siebert JS, Wahl H-W, Schröder J. The Role of Attitude Toward Own Aging for Fluid and Crystallized Functioning: 12-Year Evidence From the ILSE Study. J Gerontol B Psychol Sci Soc Sci. 28. April 2016;

Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, u. a. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer’s disease. Nat Genet. September 2017;49(9):1373–84.

Spehl TS, Frings L, Hellwig S, Weiller C, Hüll M, Meyer PT, u. a. Role of semiquantitative assessment of regional binding potential in 123I-FP-CIT SPECT for the differentiation of frontotemporal dementia, dementia with Lewy bodies, and Alzheimer’s dementia. Clin Nucl Med. Januar 2015;40(1):e27-33.

Spitzer P, Condic M, Herrmann M, Oberstein TJ, Scharin-Mehlmann M, Gilbert DF, u. a. Amyloidogenic amyloid-β-peptide variants induce microbial agglutination and exert antimicrobial activity. Sci Rep. 14. September 2016;6:32228.

Stein J, Luppa M, Kaduszkiewicz H, Eisele M, Weyerer S, Werle J, u. a. Is the Short Form of the Mini-Mental State Examination (MMSE) a better screening instrument for dementia in older primary care patients than the original MMSE? Results of the German study on ageing, cognition, and dementia in primary care patients (AgeCoDe). Psychol Assess. September 2015;27(3):895–904.

Steinacker P, Semler E, Anderl-Straub S, Diehl-Schmid J, Schroeter ML, Uttner I, u. a. Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias. Neurology. 7. März 2017;88(10):961–9.


 

 

T

 

Teipel S, Babiloni C, Hoey J, Kaye J, Kirste T, Burmeister OK. Information and communication technology solutions for outdoor navigation in dementia. Alzheimers Dement. Juni 2016;12(6):695–707.

Teipel S, Bakardjian H, Gonzalez-Escamilla G, Cavedo E, Weschke S, Dyrba M, u. a. No association of cortical amyloid load and EEG connectivity in older people with subjective memory complaints. Neuroimage Clin. 2018;17:435–43.

Teipel S, Drzezga A, Grothe MJ, Barthel H, Chételat G, Schuff N, u. a. Multimodal imaging in Alzheimer’s disease: validity and usefulness for early detection. Lancet Neurol. Oktober 2015;14(10):1037–53.

Teipel S, Ehlers I, Erbe A, Holzmann C, Lau E, Hauenstein K, u. a. Structural Connectivity Changes Underlying Altered Working Memory Networks in Mild Cognitive Impairment: A Three-Way Image Fusion Analysis. J Neuroimaging. August 2015;25(4):634–42.

Teipel S, Fritze T, Ovari A, Buhr A, Kilimann I, Witt G, u. a. Regional Pattern of Dementia and Prevalence of Hearing Impairment in Germany. J Am Geriatr Soc. August 2015;63(8):1527–33.

Teipel S, Grothe MJ, Alzheimer’s Disease Neuroimaging Initiative. Association Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and Prodromal and Dementia Stages of Alzheimer’s Disease. J Alzheimers Dis. 12. April 2016;52(4):1443–51.

Teipel S, Grothe MJ, Alzheimer´s Disease Neuroimaging Initiative. Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer’s disease? Eur J Nucl Med Mol Imaging. März 2016;43(3):526–36.

Teipel S, Grothe MJ, Zhou J, Sepulcre J, Dyrba M, Sorg C, u. a. Measuring Cortical Connectivity in Alzheimer’s Disease as a Brain Neural Network Pathology: Toward Clinical Applications. J Int Neuropsychol Soc. Februar 2016;22(2):138–63.

Teipel S, Heine C, Hein A, Krüger F, Kutschke A, Kernebeck S, u. a. Multidimensional assessment of challenging behaviors in advanced stages of dementia in nursing homes-The insideDEM framework. Alzheimers Dement (Amst). 2017;8:36–44.

Teipel SJ, Bruno D, Grothe MJ, Nierenberg J, Pomara N. Hippocampus and basal forebrain volumes modulate effects of anticholinergic treatment on delayed recall in healthy older adults. Alzheimers Dement (Amst). Juni 2015;1(2):216–9.

Teipel SJ, Cavedo E, Grothe MJ, Lista S, Galluzzi S, Colliot O, u. a. Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer’s disease. Neuropharmacology. September 2016;108:128–35.

Teipel SJ, Cavedo E, Weschke S, Grothe MJ, Rojkova K, Fontaine G, u. a. Cortical amyloid accumulation is associated with alterations of structural integrity in older people with subjective memory complaints. Neurobiol Aging. September 2017;57:143–52.

Teipel SJ, Grothe MJ, Metzger CD, Grimmer T, Sorg C, Ewers M, u. a. Robust Detection of Impaired Resting State Functional Connectivity Networks in Alzheimer’s Disease Using Elastic Net Regularized Regression. Front Aging Neurosci. 2016;8:318.

Teipel SJ, Grothe MJ, Wittfeld K, Hoffmann W, Hegenscheid K, Völzke H, u. a. Association of a neurokinin 3 receptor polymorphism with the anterior basal forebrain. Neurobiol Aging. Juni 2015;36(6):2060–7.

Teipel SJ, Keller F, Thyrian JR, Strohmaier U, Altiner A, Hoffmann W, u. a. Hippocampus and Basal Forebrain Volumetry for Dementia and Mild Cognitive Impairment Diagnosis: Could It Be Useful in Primary Care? J Alzheimers Dis. 2017;55(4):1379–94.

Teipel SJ, Kurth J, Krause B, Grothe MJ, Alzheimer’s Disease Neuroimaging Initiative. The relative importance of imaging markers for the prediction of Alzheimer’s disease dementia in mild cognitive impairment - Beyond classical regression. Neuroimage Clin. 2015;8:583–93.

Teipel SJ, Thyrian JR, Hertel J, Eichler T, Wucherer D, Michalowsky B, u. a. Neuropsychiatric symptoms in people screened positive for dementia in primary care. Int Psychogeriatr. Januar 2015;27(1):39–48.

Teipel S, Kilimann I, Thyrian JR, Klöppel S, Hoffmann W. Potential role of neuroimaging markers for early diagnosis of dementia in primary care. Curr Alzheimer Res. 7. September 2017;

Teipel S, Raiser T, Riedl L, Riederer I, Schroeter ML, Bisenius S, u. a. Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasia. Cortex. Oktober 2016;83:124–35.

Tesky VA, Köbe T, Witte AV, Flöel A, Schuchardt JP, Hahn A, u. a. Feasibility and first results of a group program to increase the frequency of cognitively stimulating leisure activities in people with mild cognitive impairment (AKTIVA-MCI). Clin Interv Aging. 2017;12:1459–69.

Then FS, Luck T, Angermeyer MC, Riedel-Heller SG. Education as protector against dementia, but what exactly do we mean by education? Age Ageing. Juli 2016;45(4):523–8.

Then FS, Luck T, Heser K, Ernst A, Posselt T, Wiese B, u. a. Which types of mental work demands may be associated with reduced risk of dementia? Alzheimers Dement. April 2017;13(4):431–40.

Thielen J-W, Kärgel C, Müller BW, Rasche I, Genius J, Bus B, u. a. Aerobic Activity in the Healthy Elderly Is Associated with Larger Plasticity in Memory Related Brain Structures and Lower Systemic Inflammation. Front Aging Neurosci. 2016;8:319.

Thyrian JR, Hertel J, Wucherer D, Eichler T, Michalowsky B, Dreier-Wolfgramm A, u. a. Effectiveness and Safety of Dementia Care Management in Primary Care: A Randomized Clinical Trial. JAMA Psychiatry. 1. Oktober 2017;74(10):996–1004.

Tiepolt S, Hesse S, Patt M, Luthardt J, Schroeter ML, Hoffmann K-T, u. a. Early [(18)F]florbetaben and [(11)C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer’s disease. Eur J Nucl Med Mol Imaging. August 2016;43(9):1700–9.

Tuszynski T, Rullmann M, Luthardt J, Butzke D, Tiepolt S, Gertz H-J, u. a. Evaluation of software tools for automated identification of neuroanatomical structures in quantitative β-amyloid PET imaging to diagnose Alzheimer’s disease. Eur J Nucl Med Mol Imaging. Juni 2016;43(6):1077–87.


U

 

Urbanowitsch N, Degen C, Toro P, Schröder J. Neurological soft signs in aging, mild cognitive impairment, and Alzheimer’s disease - the impact of cognitive decline and cognitive reserve. Front Psychiatry. 2015;6:12.


 

V

 

van Waalwijk van Doorn LJC, Koel-Simmelink MJ, Haußmann U, Klafki H, Struyfs H, Linning P, u. a. Validation of soluble amyloid-β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseases. J Neurochem. April 2016;137(1):112–21.

Verhülsdonk S, Hellen F, Höft B, Supprian T, Lange-Asschenfeldt C. Attention and CERAD test performances in cognitively impaired elderly subjects. Acta Neurol Scand. Juni 2015;131(6):364–71.

Verhülsdonk S, Lange-Asschenfeldt C, Höft B, Schwender H, Supprian T, Hellen F, u. a. Repressive Coping Does Not Contribute to Anosognosia in First-Diagnosis Patients With Alzheimer Disease. Alzheimer Dis Assoc Disord. September 2017;31(3):249–55.

Verhülsdonk S, Supprian T, Höft B. [Geriatric psychiatric home counseling for people with dementia and anosognosia : Results of a model project]. Z Gerontol Geriatr. April 2017;50(3):219–25.

Voigt-Radloff S, de Werd MME, Leonhart R, Boelen DHE, Olde Rikkert MGM, Fliessbach K, u. a. Structured relearning of activities of daily living in dementia: the randomized controlled REDALI-DEM trial on errorless learning. Alzheimers Res Ther. 23. März 2017;9(1):22.

Vos SJB, Verhey F, Frölich L, Kornhuber J, Wiltfang J, Maier W, u. a. Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage. Brain. Mai 2015;138(Pt 5):1327–38.


 

W

 

Wagner M, Wolfsgruber S, Gaertner B, Kleineidam L, Buttery AK, Jacobi F, u. a. Cognitive functioning in the general population: Factor structure and association with mental disorders-The neuropsychological test battery of the mental health module of the German Health Interview and Examination Survey for Adults (DEGS1-MH). Int J Methods Psychiatr Res. 6. November 2017;

Weise D, Tiepolt S, Awissus C, Hoffmann K-T, Lobsien D, Kaiser T, u. a. Critical Comparison of Different Biomarkers for Alzheimer’s Disease in a Clinical Setting. J Alzheimers Dis. 2015;48(2):425–32.

Wessa M, King AV, Meyer P, Frölich L, Flor H, Poupon C, u. a. Impaired and preserved aspects of feedback learning in aMCI: contributions of structural connectivity. Brain Struct Funct. Juni 2016;221(5):2831–46.

Wettstein M, Wahl H-W, Shoval N, Oswald F, Voss E, Seidl U, u. a. Out-of-home behavior and cognitive impairment in older adults: findings of the SenTra Project. J Appl Gerontol. Februar 2015;34(1):3–25.

Witte AV, Köbe T, Graunke A, Schuchardt JP, Hahn A, Tesky VA, u. a. Impact of leptin on memory function and hippocampal structure in mild cognitive impairment. Hum Brain Mapp. Dezember 2016;37(12):4539–49.

Wolfsgruber S, Jessen F, Koppara A, Kleineidam L, Schmidtke K, Frölich L, u. a. Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI. Neurology. 24. März 2015;84(12):1261–8.

Wolfsgruber S, Kleineidam L, Wagner M, Mösch E, Bickel H, Lϋhmann D, u. a. Differential Risk of Incident Alzheimer’s Disease Dementia in Stable Versus Unstable Patterns of Subjective Cognitive Decline. J Alzheimers Dis. 4. Oktober 2016;54(3):1135–46.

Wolfsgruber S, Polcher A, Koppara A, Kleineidam L, Frölich L, Peters O, u. a. Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment. J Alzheimers Dis. 2017;58(3):939–50.

Wucherer D, Thyrian JR, Eichler T, Hertel J, Kilimann I, Richter S, u. a. Drug-related problems in community-dwelling primary care patients screened positive for dementia. Int Psychogeriatr. November 2017;29(11):1857–68.

Wucherer D, Eichler T, Hertel J, Kilimann I, Richter S, Michalowsky B, u. a. Potentially Inappropriate Medication in Community-Dwelling Primary Care Patients who were Screened Positive for Dementia. J Alzheimers Dis. 2017;55(2):691–701.

Wucherer D, Eichler T, Kilimann I, Hertel J, Michalowsky B, Thyrian JR, u. a. Antidementia drug treatment in people screened positive for dementia in primary care. J Alzheimers Dis. 2015;44(3):1015–21.


Y

 

Yordanova K, Koldrack P, Heine C, Henkel R, Martin M, Teipel S, u. a. Situation Model for Situation-Aware Assistance of Dementia Patients in Outdoor Mobility. J Alzheimers Dis. 2017;60(4):1461–76.

Yüksel D, Dietsche B, Forstner AJ, Witt SH, Maier R, Rietschel M, u. a. Polygenic risk for depression and the neural correlates of working memory in healthy subjects. Prog Neuropsychopharmacol Biol Psychiatry. 3. Oktober 2017;79(Pt B):67–76.

 


 

Z

 

Zenthöfer A, Baumgart D, Cabrera T, Rammelsberg P, Schröder J, Corcodel N, u. a. Poor dental hygiene and periodontal health in nursing home residents with dementia: an observational study. Odontology. April 2017;105(2):208–13.

Zenthöfer A, Meyer-Kühling I, Hufeland A-L, Schröder J, Cabrera T, Baumgart D, u. a. Carers’ education improves oral health of older people suffering from dementia - results of an intervention study. Clin Interv Aging. 2016;11:1755–62.

Zoicas I, Reichel M, Gulbins E, Kornhuber J. Role of Acid Sphingomyelinase in the Regulation of Social Behavior and Memory. PLoS ONE. 2016;11(9):e0162498.

Zwingmann I, Hoffmann W, Michalowsky B, Dreier-Wolfgramm A, Hertel J, Wucherer D, u. a. Supporting family dementia caregivers: testing the efficacy of dementia care management on multifaceted caregivers’ burden. Aging Ment Health. 20. November 2017;1–8.